Expert Opinion on Pharmacotherapy : Impact Factor & More
eISSN: 1744-7666pISSN: 1465-6566
Share this on:
Aims and Scope of Expert Opinion on Pharmacotherapy
Expert Opinion on Pharmacotherapy is a peer-reviewed medical journal publishing review articles and original papers on new pharmacotherapies. It is published by Informa and the editor-in-chief is Dimitri P. Mikhailidis (Royal Free Hospital). Less
Key Metrics
CiteScore 
5.5
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
0.99
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Expert Opinion on Pharmacotherapy
Expert Opinion on Pharmacotherapy Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2000 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Expert Opinion on Pharmacotherapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Expert Opinion on Pharmacotherapy
Pharmacotherapeutic landscape for the management of agitation associated with Alzheimer’s disease
- 24 Apr 2026
- Expert Opinion on Pharmacotherapy
Phenotypic response surface-guided pharmacotherapy for personalized combination treatment in complex diseases
- 19 Apr 2026
- Expert Opinion on Pharmacotherapy
New and currently investigated pharmacotherapies for the erythropoietic protoporphyrias: spotlight on dersimelagon and bitopertin
- 18 Apr 2026
- Expert Opinion on Pharmacotherapy
New perspectives in managing chronic pelvic pain in endometriosis: the role of GnRH antagonists versus dienogest
- 17 Apr 2026
- Expert Opinion on Pharmacotherapy
Optimizing the use of novel systemic therapies in atopic dermatitis: an insight into therapeutic transitions
- 16 Apr 2026
- Expert Opinion on Pharmacotherapy
Pancreatic cancer: emerging small molecule pharmacotherapies
- 14 Apr 2026
- Expert Opinion on Pharmacotherapy
Pharmacotherapeutic landscape for the management of agitation associated with Alzheimer’s disease
- 24 Apr 2026
- Expert Opinion on Pharmacotherapy
Phenotypic response surface-guided pharmacotherapy for personalized combination treatment in complex diseases
- 19 Apr 2026
- Expert Opinion on Pharmacotherapy
New and currently investigated pharmacotherapies for the erythropoietic protoporphyrias: spotlight on dersimelagon and bitopertin
- 18 Apr 2026
- Expert Opinion on Pharmacotherapy
New perspectives in managing chronic pelvic pain in endometriosis: the role of GnRH antagonists versus dienogest
- 17 Apr 2026
- Expert Opinion on Pharmacotherapy
Optimizing the use of novel systemic therapies in atopic dermatitis: an insight into therapeutic transitions
- 16 Apr 2026
- Expert Opinion on Pharmacotherapy
Pancreatic cancer: emerging small molecule pharmacotherapies
- 14 Apr 2026
- Expert Opinion on Pharmacotherapy
FAQs on Expert Opinion on Pharmacotherapy
How long has Expert Opinion on Pharmacotherapy been actively publishing? 
What is the publishing frequency of Expert Opinion on Pharmacotherapy?
How many articles did Expert Opinion on Pharmacotherapy publish last year?
What is the eISSN & pISSN for Expert Opinion on Pharmacotherapy?
What is Citescore for Expert Opinion on Pharmacotherapy?
What is SNIP score for Expert Opinion on Pharmacotherapy?
What is the SJR for Expert Opinion on Pharmacotherapy?
Who is the publisher of Expert Opinion on Pharmacotherapy?
